Life Sciences BPO Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

  • 455 views
Uploaded on

The global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to …

The global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019.Economic burden, increased financial crisis and technological advances has compelled all pharmaceutical, biotechnology and life science companies to outsource their R&D activities and manufacturing processes in order to achieve their cost benefits and save time.In recent years, large number of life science companies has modified their traditional drug manufacturing operationswith more focus now on their core R&D activities and manufacturing processes via outsourcing. At present, new outsourcing strategies and types of services are developing in almost every stage of research and manufacturing process.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
455
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Transparency Market Research (TMR) provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business & market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. Contact Us : State Tower,90 State Street,Suite 700,Albany NY – 12207,United States Tel: +1-518-618-1030 Email: sales@transparencymarketresearch.com
  • 2. Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019 Single User License: US $ 4795 Buy Now Request Sample Multi User License: US $ 7795 206 Pages Report Corporate User License: US $ 10795 Published Date : Feb 2014
  • 3. PR : Life Sciences BPO Market is Expected to Reach USD 596.0 Billion Globally in 2019: Transparency Market Research Transparency Market Research is Published new Market Report " Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019. Rising cost, growing complexities of conducting clinical trials and increased pressure from regulatory agencies to adopt various techniques to minimize the costs involved for successful introduction of a drug in the market has compelled pharmaceutical players to adopt new outsourcing models. All these factors have helped fuel market growth of the Life Sciences BPO industry in the past decade. In addition, rise in the number of patent expirations and failure of drugs during the clinical trials process has triggered the overall growth of pharmaceutical outsourcing industry. Moreover, outsourcing aids the biotechand pharmaceutical industry to focus on their core strategies and utilize their internal resources for more critical in-house projects. The Contract Manufacturing Organizations (CMOs) outsourcing services accounts for the largest segment of the overall Life Sciences BPO market. Growing healthcare costs has led to a rise in the demand for generic drugs and this has consequently led to growth in demand for active pharmaceutical outsourcing services. Moreover, CMOs conduct internal R&D to come up with novel technologies to further support their clients. The API manufacturing market accounts to be largest segment of the total CMO market. This growth has been attributed to increase in outsourcing activities for pharmaceutical manufacturing outsourcing, owing to increasing regulatory compliance such cGMP and other approvals. Moreover, manufacturers do not have all the technologies and expertise available in-house required for manufacturing different APIs and hence, outsourcing serves as a more cost effective solution for pharmaceutical companies. Also, the growing importance of biological drugs calls for distinctive manufacturing technology. The Contract Research Organizations (CROs) outsourcing services market has also witnessed significant growth in the past decade. This growth has been attributed to the rising costs involved in conducting various phases of clinical trials ranging from drug discovery up to post marketing approvals. Pharmaceutical companies are now opting to
  • 4. outsource their clinical trial activities to vendorscapable of providing bundled services such as regulatory services, clinical data management, medical writing, site management, pharmacovigilance, risk based monitoring, biostatics, protocol development and others. The drug discovery services segment accounted for the largest market share in 2012.Since a large number of molecules fail during the drug discovery process, through outsourcing the pharmaceutical companies are mitigating their financial risks and avoiding sunken costs through partnership with CROs. However, clinical data management outsourcing services market is expected to foresee the highest growth rate of 17.3% from 2013 to 2019. This high growth has been attributed to the growing adoption of advanced IT services such cloud applications and enhanced software services provided by Information Technology Outsourcing (ITO). Data security and Intellectual Property Rights (IPR)still persist to be major hindrance for growth of this industry. Browse Life Sciences BPO Market Report with Full TOC at http://www.transparencymarketresearch.com/life-sciences-bpo-market.html Geographically, North America accounted for the largest share of the global pharmaceutical outsourcing services market in 2012 and was valued at USD 28.4 billion in 2012 followed by Asia-Pacific. The Asian-Pacific region is expected to represent the highest growth rate of 21.2% during the forecast period owing to availability of trained resources, low cost labor, favorable regulatory policies and huge patient pool suffering from varies chronic diseases. Moreover, the companies from this region are now meeting the required manufacturing and quality standards of the USFDA and EMEA to further boost market growth. The major players in this market include Catalent Pharma Solutions, Lonza Group, Parexel International, PRA International, Piramal Healthcare, Charles River Laboratories, PPD (Pharmaceutical Product Development), Cognizant, Accenture, IBM, Quintiles, Covance and others. The global life sciences BPO market is segmented as follows: Global Life Sciences BPO Market, by Segments  Pharmaceutical Outsourcing Market  Contract Manufacturing Organizations (CMOs)  Active Pharmaceutical Ingredients (APIs) Manufacturing  Finished Dosage Formulation (FDF) Development and Manufacturing  Packaging  Contract Research Organizations (CROs)  Drug Discovery
  • 5.  Pre-Clinical Studies  Clinical Studies  Medical Writing  Clinical Data Management (CDM)  Bio-Statistics  Risk Based Monitoring  Site Management  Pharmacovigilance  Regulatory Services  Protocol Development  Others  Contract Sales Organizations (CSOs) Global Life Sciences BPO Market, by Geography  North America  Europe  Germany  France  U.K.  Italy  Spain  Switzerland  ROE  Asia-Pacific  Rest of the World (RoW)
  • 6. Related & Recently Published Reports by Transparency Market Research  Ophthalmic Drugs Market: http://www.transparencymarketresearch.com/ophthalmic-drugsmarket.html  Contact Lens Market: http://www.transparencymarketresearch.com/contact-lens-market.html  Molecular Diagnostics Market: http://www.transparencymarketresearch.com/molecular-diagnosticsindustry.html  Blood Flow Measurement Devices: http://www.transparencymarketresearch.com/blood-flow-measurementdevices.html  Building and Construction Plastics Market: http://www.transparencymarketresearch.com/building-constructionplastics-market.html  Organ Preservation Solutions Market: http://www.transparencymarketresearch.com/organ-preservationsolutions.html Table of Content Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation Chapter 2 Executive Summary 2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019)
  • 7. 2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion) 2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion) 2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion) Chapter 3 Global Life Sciences BPO Market Dynamics 3.1 Introduction 3.1.1 Drivers 3.1.1.1 Rising cost of R&D and decline in productivity 3.1.1.2 Patent expirations to boost CMO industry growth 3.1.1.3 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions 3.1.1.4 Restructuring of pharmaceutical production 3.1.2 Restraints 3.1.2.1 Data safety concerns 3.1.2.2 Stringent and varied regulatory approval processes in different countries 3.1.2.3 Unforeseen Costs has marred the growth of CRO industry 3.1.3 Opportunities 3.1.3.1 Biologics 3.1.3.2 Emerging markets 3.2 Value Chain Analysis 3.2.1 People Skills and Challenges for Life Sciences BPO Services: 3.2.2 Pharmaceutical Outsourcing 3.2.3 Contract Research Outsourcing Market: 3.2.4 Value Chain Analysis: Contract Research Outsourcing Market 3.2.5 Contract Research Outsourcing Services (%), 2012
  • 8. 3.2.5.1 Contract Research Outsourcing Services (%), 2012 3.2.6 Pharmacovigilance 3.2.6.1 Value Chain Analysis: Pharmacovigilance 3.2.7 Biostatistics 3.2.7.1 Value Chain Analysis: Biostatistics 3.2.8 Risk-based Monitoring 3.2.8.1 Value Chain Analysis: Risk based Monitoring 3.2.9 Study Design and Protocol Development 3.2.9.1 Value Chain Analysis: Study Design and Protocol Development 3.2.10 Medical Writing 3.2.10.1 Value Chain Analysis: Medical Writing 3.2.11 Clinical Data Management 3.2.11.1 Value Chain Analysis: Clinical Data Management 3.2.12 Site Management 3.2.12.1 Value Chain Analysis: Site Management 3.2.13 Regulatory Services 3.2.13.1 Value Chain Analysis: Regulatory Services 3.3 Porter’s Five Force Analysis: Global Life sciences BPO Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of New Entrants 3.3.4 Threat of Substitutes 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography 3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
  • 9. 3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe 3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography Chapter 4 Global Life Sciences BPO Market, by Segments 4.1 Overview 4.2 Pharmaceutical Outsourcing 4.2.1 Contract Manufacturing Outsourcing 4.2.1.1 Active Pharmaceutical Ingredients (API) Manufacturing 4.2.1.1.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion) 4.2.1.2 Final Dosage Form (FDF) Manufacturing 4.2.1.2.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion) 4.2.1.3 Packaging 4.2.1.3.1 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion) 4.2.2 Contract Research Outsourcing 4.2.2.1 Drug Discovery 4.2.2.1.1 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.2 Pre-Clinical Studies 4.2.2.2.1 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.3 Early Phase Clinical Research Services (Phase I / IIa) 4.2.2.3.1 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.4 Phase IIb / IIIa
  • 10. 4.2.2.4.1 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.5 Phase IIIb / IV (Peri/Post Approval Phase / Post Marketing Surveillance) 4.2.2.5.1 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.6 Medical Writing 4.2.2.6.1 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.7 Pharmacovigilance 4.2.2.7.1 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.8 Clinical Data Management 4.2.2.8.1 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.9 Regulatory Services 4.2.2.9.1 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.10 Clinical Monitoring 4.2.2.10.1 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.11 Biostatistics 4.2.2.11.1 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.12 Protocol Development 4.2.2.12.1 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion) 4.2.2.13 Site Management 4.2.2.13.1 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
  • 11. Chapter 5 Global Life Sciences BPO Market, by Geography 5.1 Overview 5.1.1 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion) 5.1.2 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3 Europe 5.3.1 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.2 Germany 5.3.2.1 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.2.2 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.2.3 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.3 U.K. 5.3.3.1 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.3.2 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2-019 (USD Billion) 5.3.3.3 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.4 France 5.3.4.1 France Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.4.2 France Contract Manufacturing Outsourcing Service Market, 2011 – 2019 (USD Million) 5.3.4.3 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.5 Italy 5.3.5.1 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
  • 12. 5.3.5.2 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.5.3 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.6 Spain 5.3.6.1 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.6.2 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.6.3 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.7 Switzerland 5.3.7.1 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.7.2 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.7.3 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.8 Rest of Europe (ROE) 5.3.8.1 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.3.8.2 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million) 5.3.8.3 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion) 5.5 RoW 5.5.1 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)
  • 13. Chapter 6 Global Life Sciences BPO Market Share Analysis 6.1 Market Share Analysis by Key Players of Global CRO Market 6.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%) 6.2 Market Share Analysis by Key Players of Global CMO Market 6.2.1 Global CMO Market Share Analysis, by Key Players, 2012 (%) Chapter 7 Recommendations 7.1 Success Strategies 7.1.1 Expand Market into Emerging Countries 7.1.2 Ensure Data Confidentiality and Regulatory Compliance 7.1.3 Timely Entry in the Market 7.1.4 Offer a Wide Range of Research and Manufacturing Services 7.1.5 Developing Strategic Alliances and Partnerships With Pharmaceutical and Biotechnology Companies 7.1.6 Risk Management Chapter 8 Company Profiles 8.1 Accenture, Plc 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.4.1 Mergers and acquisitions 8.1.5 Recent Developments 8.2 Boehringer Ingelheim GmbH 8.2.1 Company Overview
  • 14. 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.4.1 Research And Development For Medical Innovation 8.2.5 Recent Developments 8.3 Catalent Pharma Solutions, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.4.1 Geographical expansion of business 8.3.4.2 Diversification of product portfolio 8.3.5 Recent Developments 8.4 Charles River Laboratories International, Inc. (CRL) 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.4.1 Expansion of services offered 8.4.4.2 New product launches and Innovation 8.4.4.3 Strategic acquisitions 8.4.5 Recent Developments 8.5 Cognizant Technology Solutions 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio
  • 15. 8.5.4 Business Strategies 8.5.4.1 Expansion of geographical footprint 8.5.4.2 Expansion product portfolio 8.5.4.3 Highly-skilled manpower 8.5.4.4 Strategic acquisitions 8.5.5 Recent Developments 8.6 Covance, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.4.1 New product development and innovation 8.6.4.2 Agreements and collaborations 8.6.4.3 Strategic acquisitions 8.6.4.4 Geographical expansion of business 8.6.5 Recent Developments 8.7 DSM 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.4.1 Strategic acquisitions 8.7.5 Recent Developments 8.8 Fareva 8.8.1 Company Overview 8.8.2 Product Portfolio
  • 16. 8.8.3 Business Strategies 8.8.3.1 Extensive product portfolio 8.8.3.2 Safety environment for staff 8.8.3.3 Commitment to quality 8.8.4 Recent Developments 8.9 ICON, Plc 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.4.1 Business expansion in APAC region 8.9.4.2 Expansion of services offered 8.9.5 Recent Developments 8.10 Infosys 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.4.1 Extensive product portfolio 8.10.4.2 Geographical expansion of business 8.10.5 Recent Developments 8.11 International Business Machines Corporation 8.11.1 Company overview 8.11.2 Financial overview 8.11.3 Product Portfolio 8.11.4 Business strategies
  • 17. 8.11.4.1 Focus on increasing facilities for predictive analytics 8.11.4.2 Geographic Expansion 8.11.5 Recent developments 8.12 Lonza Group 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.4.1 Investment in emerging economies 8.12.4.2 Mergers and acquisitions 8.12.5 Recent Developments 8.13 Pharmaceutical Product Development, Inc. (PPD, Inc.) 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategies 8.13.4.1 Expanding geographic presence 8.13.4.2 Incorporation of innovative technologies 8.13.4.3 Strategic acquisitions 8.13.4.4 New product launch and innovation 8.13.5 Recent Developments 8.14 Parexel International Corporation 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio 8.14.4 Business Strategies
  • 18. 8.14.4.1 Strong presence in Asia and emerging markets 8.14.4.2 Strategic alliances 8.14.4.3 Mergers & Acquisitions 8.14.5 Recent Developments 8.15 Patheon, Inc. 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio 8.15.4 Business Strategies 8.15.4.1 Strategic acquisitions 8.15.4.2 Geographical expansion of business 8.15.5 Recent Developments 8.16 Piramal Healthcare 8.16.1 Company Overview 8.16.2 Financial Overview 8.16.3 Product Portfolio 8.16.4 Business Strategies 8.16.4.1 Expansion of services offered 8.16.5 Recent Developments 8.17 PRA International, Inc. 8.17.1 Company Overview 8.17.2 Financial Overview 8.17.3 Product Portfolio 8.17.4 Business Strategies 8.17.4.1 Mergers and acquisitions 8.17.5 Recent Developments
  • 19. 8.18 Quintiles Transnational Corporation 8.18.1 Company Overview 8.18.2 Financial Overview 8.18.3 Product Portfolio 8.18.4 Business Strategies 8.18.4.1 Expansion of services 8.18.4.2 Acquisitions and partnerships 8.18.4.3 Innovation in services offered 8.18.5 Recent Developments 8.19 Wipro Limited 8.19.1 Company Overview 8.19.2 Financial Overview 8.19.3 Product Portfolio 8.19.4 Business Strategies 8.19.4.1 Geographical Expansion Chapter 9 List of the Companies 9.1 List of Companies Offering Contract Research Outsourcing Services in North America. 9.3 List of Companies Offering Contract Research Outsourcing Services in Europe. 9.3.1 List of Contract Research Organizations in France 9.3.2 List of Contract Research Organizations in Italy 9.3.4 List of Contract Research Organizations in Germany 9.3.5 List of Contract Research Organizations in Spain 9.3.6 List of Contract Research Organizations in United Kingdom 9.3.7 List of Contract Research Organizations in Switzerland
  • 20. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports1.html Contact us : Sheela AK 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Web: http://www.transparencymarketresearch.com/ Blog : http://heavyindustrynews.wordpress.com/